Perez-Mingan G, Sierra-Merlano R, Yepes I, Vergara M, Ortiz M, Pena B
Genes (Basel). 2025; 15(12.
PMID: 39766906
PMC: 11675702.
DOI: 10.3390/genes15121639.
Noguerol E, Ferreira de Souza L, Muglia V, Elias Jr J
Radiol Bras. 2024; 57:e20240009en.
PMID: 39563789
PMC: 11575847.
DOI: 10.1590/0100-3984.2024.0009-en.
Lampsas S, Marinos G, Lambrinos D, Theofilis P, Gialamas I, Pantelidis P
Am J Lifestyle Med. 2024; :15598276241267213.
PMID: 39554921
PMC: 11562271.
DOI: 10.1177/15598276241267213.
Yu L, Que T, Zhou Y, Liu Z
Front Nutr. 2024; 11:1437681.
PMID: 39410926
PMC: 11476413.
DOI: 10.3389/fnut.2024.1437681.
Han T, Li Y, Xiao J, Gong H, Deng F, Jiang W
Diabetes Metab Syndr Obes. 2024; 17:3547-3556.
PMID: 39328264
PMC: 11424687.
DOI: 10.2147/DMSO.S469398.
The interaction of genetics and physical activity in the pathogenesis of metabolic dysfunction associated liver disease.
Frostdahl H, Ahmad N, Hammar U, Mora A, Langner T, Fall T
Sci Rep. 2024; 14(1):17817.
PMID: 39090170
PMC: 11294342.
DOI: 10.1038/s41598-024-68271-4.
Triglyceride-glucose-alanine aminotransferase index: A noninvasive serum predictor for identifying the severity of pediatric nonalcoholic fatty liver disease.
Noh E, Hwang I
Medicine (Baltimore). 2024; 103(26):e38241.
PMID: 38941428
PMC: 11466171.
DOI: 10.1097/MD.0000000000038241.
Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study.
Gosnell J, Golovko G, Arroyave E, Moghe A, Kueht M, Saldarriaga O
World J Diabetes. 2024; 15(5):886-897.
PMID: 38766421
PMC: 11099377.
DOI: 10.4239/wjd.v15.i5.886.
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review.
Ghazanfar H, Javed N, Qasim A, Sarin Zacharia G, Ghazanfar A, Jyala A
Cancers (Basel). 2024; 16(6).
PMID: 38539547
PMC: 10969013.
DOI: 10.3390/cancers16061214.
Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease.
Cheng W, Wong P, Wu C, Cheng P, Lee P, Li C
Environ Health Prev Med. 2024; 29:7.
PMID: 38346730
PMC: 10898959.
DOI: 10.1265/ehpm.23-00271.
The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease.
Van Eyck A, Kwanten W, Peleman C, Makhout S, Van Laere S, Van De Maele K
Int J Obes (Lond). 2023; 48(4):512-522.
PMID: 38142264
DOI: 10.1038/s41366-023-01443-w.
Effect of nano-micelle curcumin on hepatic enzymes: A new treatment approach for non-alcoholic fatty liver disease (NAFLD).
Namdar A, Ahadi M, Hoseini S, Vosoghinia H, Rajablou H, Farsi S
Avicenna J Phytomed. 2023; 13(6):615-625.
PMID: 38106627
PMC: 10719728.
DOI: 10.22038/AJP.2023.21919.
Application of Interpretable Machine Learning Models Based on Ultrasonic Radiomics for Predicting the Risk of Fibrosis Progression in Diabetic Patients with Nonalcoholic Fatty Liver Disease.
Meng F, Wu Q, Zhang W, Hou S
Diabetes Metab Syndr Obes. 2023; 16:3901-3913.
PMID: 38077485
PMC: 10700041.
DOI: 10.2147/DMSO.S439127.
Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD.
Park S, Park J, Kwon S, Lee Y, Kim G, Hur K
Sci Rep. 2023; 13(1):10677.
PMID: 37393407
PMC: 10314928.
DOI: 10.1038/s41598-023-37858-8.
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial.
Dichtel L, Corey K, Haines M, Chicote M, Lee H, Kimball A
J Clin Endocrinol Metab. 2023; 108(12):e1542-e1550.
PMID: 37379033
PMC: 10655511.
DOI: 10.1210/clinem/dgad375.
Serum vitamin C levels and risk of non-alcoholic fatty liver disease: results from a cross-sectional study and Mendelian randomization analysis.
Wu H, Guo J, Yao J, Yu J, Xia R, Huang W
Front Nutr. 2023; 10:1162031.
PMID: 37252248
PMC: 10213341.
DOI: 10.3389/fnut.2023.1162031.
Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults.
Lee H, Shon J, Park Y
Nutrients. 2023; 15(10).
PMID: 37242268
PMC: 10220598.
DOI: 10.3390/nu15102385.
Role of Dual-Contingency Management in Family-Based Obesity Therapy and the Effects of Weight Loss on Liver Transient Elastography Parameters in Youth: A Pilot Study.
Majumdar I, Talal A, Harmon C, Tabaczynsk E, Cercone K, Wrotniak B
Cureus. 2023; 15(3):e36629.
PMID: 37155438
PMC: 10122838.
DOI: 10.7759/cureus.36629.
Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
Chung K, Legaki A, Papadopoulos G, Gercken B, Gebler J, Schwabe R
Int J Mol Sci. 2023; 24(5).
PMID: 36902241
PMC: 10002755.
DOI: 10.3390/ijms24054813.
PPARα activation partially drives NAFLD development in liver-specific Hnf4a-null mice.
Kasano-Camones C, Takizawa M, Ohshima N, Saito C, Iwasaki W, Nakagawa Y
J Biochem. 2023; 173(5):393-411.
PMID: 36779417
PMC: 10433406.
DOI: 10.1093/jb/mvad005.
